Rachel Reckner

VP, Marketing

Rachel has almost 20 years of commercialization experience in the healthcare industry. She has held sales, market research, and marketing roles on US, Japanese, and Global teams. Rachel was a brand director for a novel basal insulin and a brand leader for Baqsimi (Nasal Glucagon) at Eli Lilly and Company. After leaving Lilly she joined Astra Zeneca to lead their Type 1 diabetes commercialization program. Rachel earned her Bachelor of Arts from the University of Texas at Austin and an MBA from Texas A&M University.

What drew you to work in the diabetes industry?


What draws me to diabetes is that so many journal articles speak about it in terms of HbA1c, BMI, etc., but we know that life and health can’t be summed up by a number. Life is messy, unpredictable, wonderful, and challenging. I want to make sure we take a human-centric approach to understanding people with diabetes and go beyond the numbers. Everyone has a story to tell and by understanding that story our company will connect more meaningfully with the people we serve.




Why did you choose to work at Beta Bionics?


I was lucky enough to be exposed to Ed Damiano’s work years ago by a mentor. She showed me a video of his collaboration with Friends for Life and I remember thinking that this was something very special in the making. So when I had the chance to join the team, I jumped right in. There are very few times in your life when you get the chance to be a part of something groundbreaking.




What is something you are passionate about?


In addition to advancing solutions for people with diabetes? I’m also passionate about understanding how to help the elderly. We have a giant shift in age demographics taking place not just here in the US but in many developed countries. Our seniors deserve to grow old with dignity and security, but it’s so challenging with a complex healthcare system to navigate, limited transportation options, and increasing loneliness as their world gets smaller. I try to find ways to have an impact, whether that’s delivering food to the housebound or taking my little dog to visit folks in a retirement home. Our generation will be judged by how we care for our seniors.





CAUTION: The iLet® bionic pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale.

© 2021 Beta Bionics, Inc. Beta Bionics® and iLet® are registered trademarks of Beta Bionics, Inc. All rights reserved. All other trademarks are the property of their respective owners. The use of third-party trademarks does not constitute an endorsement or imply a relationship or other affiliation.